Form 4: CervoMed Inc. CFO & GC Acquires 27,000 Stock Options
SEC Form 4 Filing
William Robert Elder, CFO & GC of CervoMed Inc., reports the acquisition of 27,000 stock options on February 4, 2025, exercisable at $2.30, vesting monthly over 36 months.
Summary
- On February 14, 2025, William Robert Elder, the CFO & GC of CervoMed Inc., filed a Form 4.
- The form reports a transaction that occurred on February 4, 2025, where Elder acquired 27,000 stock options.
- These options have an exercise price of $2.30.
- The options vest in 36 equal monthly installments starting February 28, 2025.
- The options expire on February 4, 2035.
- Following the reported transaction, Elder directly owns 27,000 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option grants.
Industry Context
This filing is a routine disclosure of stock option grants to a company executive, which is a common practice in publicly traded companies to incentivize and retain key personnel.
Stakeholder Impact
- The granting of stock options aligns the executive's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of earliest transaction: acquisition of stock options. |
| 02/04/2025 | Grant date of stock options. |
| 02/14/2025 | Date of Form 4 filing. |
| 02/28/2025 | Commencement date for monthly vesting of stock options. |
| 02/04/2035 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.